Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Thomson Medical Group Ltd. ( (SG:A50) ) has issued an update.
Thomson Medical Group Limited has announced changes to its board leadership, appointing Mr Tong Kooi Ong as Chairman and Independent Non-Executive Director with effect from 1 February 2026, succeeding Mr Ng Ser Miang, who will resign on 31 January 2026. The company is also reconstituting its board committees from 1 February 2026, with updated memberships for the Audit and Risk Committee and the Nominating and Remuneration Committee, signalling a refreshed governance structure that may influence strategic oversight and risk management for shareholders and other stakeholders.
The most recent analyst rating on (SG:A50) stock is a Hold with a S$0.06 price target. To see the full list of analyst forecasts on Thomson Medical Group Ltd. stock, see the SG:A50 Stock Forecast page.
More about Thomson Medical Group Ltd.
Thomson Medical Group Limited is a Singapore-incorporated healthcare group operating in the medical sector, with a board comprising executive, non-executive, and independent directors overseeing its strategic direction and governance.
YTD Price Performance: 5.00%
Average Trading Volume: 6,358,072
Technical Sentiment Signal: Buy
Current Market Cap: S$1.67B
For detailed information about A50 stock, go to TipRanks’ Stock Analysis page.